Finucane M D, Malthouse J P
Department of Biochemistry, University College Dublin, Ireland.
Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):889-900. doi: 10.1042/bj2860889.
delta-Chymotrypsin has been alkylated by 1-13C- and 2-13C-enriched tosylphenylalanylchloromethane. In the intact inhibitor derivative, signals due to the 1-13C- and 2-13C-enriched carbon atoms have chemical shifts which titrate from 55.10 to 59.50 p.p.m. and from 99.10 to 103.66 p.p.m. respectively with similar pKa values of 8.99 and 8.85 respectively. These signals are assigned to a tetrahedral adduct formed between the hydroxy group of serine-195 and the inhibitor. An additional signal at 58.09 p.p.m. and at 204.85 p.p.m. in the 1-13C- and 2-13C-enzyme-inhibitor derivatives respectively does not titrate when the pH is changed and it is assigned to alkylated methionine-192. On denaturation/autolysis of the 1-13C-enriched enzyme-inhibitor derivative these signals associated with the intact inhibitor derivative are no longer detected, and a new signal, which titrates from 56.28 to 54.84 p.p.m. with a pKa of 5.26, is detected. The titration shift of this signal is assigned to the deprotonation of the imidazolium cation of alkylated histidine-57 in the denatured/autolysed enzyme-inhibitor derivative. Model compounds which form stable hydrates and hemiketals in aqueous solutions have been synthesized. By comparing the 13C titration shifts of these model compounds with those of the 13C enriched trypsin- and delta-chymotrypsin-inhibitor derivatives, we deduce that, in both of the intact enzyme-inhibitor derivatives, the zwitterionic tetrahedral adduct containing the imidazolium cation of histidine-57 and the hemiketal oxyanion predominates at alkaline pH values. It is estimated that in both the trypsin and delta-chymotrypsin-inhibitor derivatives the concentration of this zwitterionic tetrahedral adduct is 10,000-fold greater than it would be in water. We conclude that the pKa of the oxyanion of the hemiketal in the presence of the imidazolium cation of histidine-57 is 7.9 and 8.9 in the trypsin and delta-chymotrypsin-inhibitor derivatives respectively and that the pKa of the imidazolium cation of histidine-57 is greater than 7.9 and greater than 8.9 when the oxyanion is present as its conjugate acid, whereas, when the oxyanion is present, the pKa of the imidazolium cation is greater than 11 in both enzyme-inhibitor derivatives. We discuss how these enzymes preferentially stabilize zwitterionic tetrahedral adducts in the intact enzyme-inhibitor derivatives and how they could stabilize similar tetrahedral intermediates during catalysis. It is suggested that substrate binding could raise the pKa of the imidazolium cation of histidine-57 before tetrahedral-intermediate formation which would explain the enhanced nucleophilicity of the hydroxy group of serine-195.(ABSTRACT TRUNCATED AT 400 WORDS)
δ-胰凝乳蛋白酶已被富含1-¹³C和2-¹³C的甲苯磺酰苯丙氨酰氯甲烷烷基化。在完整的抑制剂衍生物中,富含1-¹³C和2-¹³C的碳原子产生的信号,其化学位移分别从55.10至59.50 ppm和从99.10至103.66 ppm滴定,其pKa值分别类似,为8.99和8.85。这些信号被归属于丝氨酸-195的羟基与抑制剂之间形成的四面体加合物。在1-¹³C和2-¹³C的酶-抑制剂衍生物中,分别在58.09 ppm和204.85 ppm处的另一个信号,在pH改变时不会滴定,它被归属于烷基化的甲硫氨酸-192。在富含1-¹³C的酶-抑制剂衍生物变性/自溶后,这些与完整抑制剂衍生物相关的信号不再被检测到,并且检测到一个新信号,其从56.28至54.84 ppm滴定,pKa为5.26。该信号的滴定位移被归属于变性/自溶的酶-抑制剂衍生物中烷基化组氨酸-57的咪唑鎓阳离子的去质子化。已合成在水溶液中形成稳定水合物和半缩酮的模型化合物。通过将这些模型化合物的¹³C滴定位移与富含¹³C的胰蛋白酶和δ-胰凝乳蛋白酶-抑制剂衍生物的滴定位移进行比较,我们推断,在两种完整的酶-抑制剂衍生物中,含有组氨酸-57的咪唑鎓阳离子和半缩酮氧阴离子的两性离子四面体加合物在碱性pH值下占主导。据估计,在胰蛋白酶和δ-胰凝乳蛋白酶-抑制剂衍生物中,这种两性离子四面体加合物的浓度比在水中的浓度大10000倍。我们得出结论,在组氨酸-57的咪唑鎓阳离子存在下,半缩酮氧阴离子的pKa在胰蛋白酶和δ-胰凝乳蛋白酶-抑制剂衍生物中分别为7.9和8.9,并且当氧阴离子以其共轭酸形式存在时,组氨酸-57的咪唑鎓阳离子的pKa大于7.9且大于8.9,而当氧阴离子存在时,在两种酶-抑制剂衍生物中咪唑鎓阳离子的pKa大于11。我们讨论了这些酶如何在完整的酶-抑制剂衍生物中优先稳定两性离子四面体加合物,以及它们在催化过程中如何稳定类似的四面体中间体。有人提出,底物结合可能会在四面体中间体形成之前提高组氨酸-57的咪唑鎓阳离子的pKa,这将解释丝氨酸-195羟基增强的亲核性。(摘要截断于400字)